Published in Med J Aust on April 06, 1998
Primary pulmonary hypertension: new reasons for optimism? Med J Aust (1998) 0.75
Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature (1981) 6.36
Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature (1973) 6.34
Calcitonin gene-related peptide is a potent vasodilator. Nature (1985) 6.13
Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med (1994) 4.36
Role of prostaglandin-mediated vasodilatation in inflammation. Nature (1977) 3.95
Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science (1997) 3.70
Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation. Br J Pharmacol (1979) 3.58
Validation of the diagnosis of venous thromboembolism in general practice database studies. Br J Clin Pharmacol (2000) 3.05
Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med (1995) 2.83
Lung volume reduction surgery for emphysema. Med J Aust (1997) 2.70
Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro. Nature (1988) 2.54
Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br J Pharmacol (1985) 2.38
Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a. J Exp Med (1981) 2.12
Adhesion of a human fecal Escherichia coli strain to mouse colonic mucus. Infect Immun (1985) 2.07
Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J Immunol (1998) 1.94
Evidence that neutrophil accumulation induced by interleukin-1 requires both local protein biosynthesis and neutrophil CD18 antigen expression in vivo. Br J Pharmacol (1988) 1.90
The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem Biophys Res Commun (1993) 1.88
A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives. Br J Clin Pharmacol (2000) 1.84
The six-minute walk test: a useful metric for the cardiopulmonary patient. Intern Med J (2009) 1.81
Evaluation of factors affecting the membrane filter technique for testing drinking water. Appl Environ Microbiol (1982) 1.80
Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol (1997) 1.69
Potent vasodilator activity of calcitonin gene-related peptide in human skin. J Invest Dermatol (1986) 1.68
LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin. Am J Respir Cell Mol Biol (2001) 1.64
Eotaxin and eosinophil recruitment: implications for human disease. Mol Med Today (2000) 1.62
Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol (1993) 1.62
Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J Exp Med (1997) 1.61
An anti-platelet-endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membrane. J Exp Med (1996) 1.58
Detection of the complement fragment C5a in inflammatory exudates from the rabbit peritoneal cavity using radioimmunoassay. J Exp Med (1983) 1.56
Cyclooxygenase-2: regulation and relevance in inflammation. Biochem Pharmacol (1995) 1.56
Bronchodilator reversibility in Australian adults with chronic obstructive pulmonary disease. Intern Med J (2003) 1.55
The accumulation of 111In-eosinophils induced by inflammatory mediators, in vivo. Immunology (1991) 1.55
A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo. J Exp Med (1993) 1.53
Impact of graft ischemic time on outcomes after bilateral sequential single-lung transplantation. Ann Thorac Surg (1999) 1.50
Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood (1998) 1.49
Identification and characterization of mouse small intestine mucosal receptors for Escherichia coli K-12(K88ab). Infect Immun (1986) 1.47
The MES-1 murine enhancer element is closely associated with the heterogeneous 5' ends of two divergent transcription units. Mol Cell Biol (1986) 1.47
Substance P regulates the vasodilator activity of calcitonin gene-related peptide. Nature (1988) 1.46
Evidence that endogenous nitric oxide modulates oedema formation induced by substance P. Eur J Pharmacol (1990) 1.45
Prostacyclin (PGI2) potentiates bradykinin-induced plasma exudation in rabbit skin [proceedings]. Br J Pharmacol (1978) 1.44
Interactions between the tachykinins and calcitonin gene-related peptide lead to the modulation of oedema formation and blood flow in rat skin. Br J Pharmacol (1989) 1.43
Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs. Biochem Biophys Res Commun (1994) 1.43
Imaging the Fano lattice to 'hidden order' transition in URu(2)Si(2). Nature (2010) 1.42
Endothelin induces potent microvascular constriction. Br J Pharmacol (1988) 1.42
The effect of leukotrienes C4 and D4 on the microvasculature of guinea-pig skin. Prostaglandins (1981) 1.40
An assessment of the ability of a silver-releasing device to prevent bacterial contamination of urethral catheter drainage systems. Br J Urol (1996) 1.40
Current status of genitourinary fistula. Obstet Gynecol (1988) 1.40
Chemical mediators of vascular responses in inflammation: a two mediator hypothesis [proceedings]. Br J Pharmacol (1977) 1.39
Alpha 1-adrenoceptor classification: sharpening Occam's razor. Trends Pharmacol Sci (1994) 1.38
Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase. Ann Rheum Dis (1990) 1.38
Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways. J Immunol (1999) 1.38
Proceedings:Simultaneous measurement of local plasma exudation and blood flow changes induced by intradermal injection of vasoactive substances, using [131I]albumen and 133Xe. J Physiol (1976) 1.38
Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and oedema potentiator in rabbit skin. Br J Pharmacol (1982) 1.35
Eotaxin and the attraction of eosinophils to the asthmatic lung. Respir Res (2001) 1.31
Endometriosis in 1,000 consecutive celiotomies: incidence and management. Am J Obstet Gynecol (1977) 1.30
A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry. J Biol Chem (2000) 1.29
Human C5a des Arg increases vascular permeability. J Immunol (1981) 1.28
Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. J Clin Invest (1997) 1.27
Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo. Br J Pharmacol (1993) 1.26
Measurement of rate of extravasation of plasma protein in inflammatory responses in guinea-pig skin using a continuous recording method. Br J Exp Pathol (1974) 1.26
Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: the role of specific adhesion molecules and phosphatidylinositol 3-kinase. J Exp Med (1998) 1.25
Chemoattractant cross-desensitization of the human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation. J Immunol (1997) 1.24
Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8. J Clin Invest (1995) 1.23
Eosinophil accumulation induced by human interleukin-8 in the guinea-pig in vivo. Immunology (1993) 1.23
Pho23 is associated with the Rpd3 histone deacetylase and is required for its normal function in regulation of gene expression and silencing in Saccharomyces cerevisiae. J Biol Chem (2001) 1.19
Venous thromboembolic disease and combined oral contraceptives: A re-analysis of the MediPlus database. Hum Reprod (1999) 1.17
Polymorphonuclear leukocyte-dependent plasma leakage in the rabbit skin is enhanced or inhibited by prostacyclin, depending on the route of administration. Am J Pathol (1986) 1.15
Biotechnological uses of enzymes from psychrophiles. Microb Biotechnol (2011) 1.14
Inflammatory edema induced by interactions between IL-1 and the neuropeptide calcitonin gene-related peptide. J Immunol (1991) 1.14
Histamine, leukotriene D4 and platelet-activating factor in guinea pig passive cutaneous anaphylaxis. Eur J Pharmacol (1991) 1.12
Delta 32 deletion of CCR5 gene and association with asthma or atopy. Lancet (2000) 1.12
Cytolytic therapy for the bronchiolitis obliterans syndrome complicating lung transplantation. Chest (1996) 1.11
Time-dependent synergistic interactions between the vasodilator neuropeptide, calcitonin gene-related peptide (CGRP) and mediators of inflammation. Br J Pharmacol (1991) 1.11
Epoprostenol in systemic capillary leak syndrome. Lancet (1988) 1.11
Endothelial functional responses and increased vascular permeability induced by polycations. Lab Invest (1988) 1.10
Pleural effusions and yellow nails of late onset. Postgrad Med J (1973) 1.10
The action of chemically pure SRS-A on the microcirculation in vivo. Prostaglandins (1980) 1.09
A specific antagonist of platelet-activating factor suppresses oedema formation in an Arthus reaction but not oedema induced by leukocyte chemoattractants in rabbit skin. J Immunol (1986) 1.09
Interleukin-1-induced leukocyte extravasation across rat mesenteric microvessels is mediated by platelet-activating factor. Blood (1995) 1.09
Endothelin-1: demonstration of potent effects on the microcirculation of humans and other species. J Cardiovasc Pharmacol (1989) 1.08
Prognostic implications of ploidy and proliferative activity in diffuse large cell lymphomas. Cancer Res (1986) 1.08
Maximizing thoracic organ transplant opportunities: the importance of efficient coordination. J Heart Lung Transplant (2000) 1.07
Endotoxin-induced vasodilatation in anaesthetized rat skin involves nitric oxide and prostaglandin synthesis. Br J Pharmacol (1992) 1.07
Proceedings: Inflammatory response produced by a factor released from lymphocytes. Br J Pharmacol (1972) 1.07
Relation of interlobar collaterals to radiological heterogeneity in severe emphysema. Thorax (2006) 1.07
Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation. Thorax (2000) 1.06
Eotaxin is specifically cleaved by hookworm metalloproteases preventing its action in vitro and in vivo. J Immunol (2000) 1.06
Kinetics of the generation and action of chemical mediators in zymosan-induced inflammation of the rabbit peritoneal cavity. Br J Pharmacol (1986) 1.06
Endobronchial biopsy and bronchoalveolar lavage in stable lung transplant recipients and chronic rejection. Am J Respir Crit Care Med (1998) 1.05
Potentiation of bradykinin-induced exudation following intradermal injection of particulate or colloidal materials in the rabbit: evidence for prostaglandin release and action in inflammation [proceedings]. Br J Pharmacol (1977) 1.05
Effect of a microaerosol barrier filter on the measurement of lung function. Chest (1995) 1.05
Simultaneous measurements of the accumulation of isotope-labelled protein and erythrocytes in skin reactions of allergic inflammation in the guinea-pig. Immunology (1972) 1.05
A comparative study of the neutrophil stimulatory activity in vitro and pro-inflammatory properties in vivo of 72 amino acid and 77 amino acid IL-8. J Immunol (1992) 1.04
Factor influencing survival in Stage I ovarian cancer. Am J Obstet Gynecol (1973) 1.03
Hippocampal dynorphin immunoreactivity increases in response to gonadal steroids and is positioned for direct modulation by ovarian steroid receptors. Neuroscience (2008) 1.02